Condition

Low Grade Upper Tract Urothelial Carcinoma clinical trials and research

• 2Clinical trials
• 4Countries

All recruiting trials (2)

• Dabogratinib treatment for low-grade upper tract urothelial carcinoma

  This trial tests whether the oral drug dabogratinib can shrink or control low-grade upper tract urothelial carcinoma in adults who can provide tissue or urine for genomic testing.

  Recruiting at 36 sites Phase 2 Tyra Biosciences, Inc · Loma Linda, California and 35 other locations · NCT07265947

• Nadofaragene firadenovec delivered into the renal pelvis for low-grade upper tract urothelial cancer

  This trial tests whether Nadofaragene firadenovec given into the renal pelvis is safe and tolerable for adults with biopsy-proven low-grade upper tract urothelial carcinoma.

  Recruiting at 9 sites Phase 1/2 Ferring Pharmaceuticals · Scottsdale, Arizona and 8 other locations · NCT06668493

Quick answers

How many Low Grade Upper Tract Urothelial Carcinoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in France (2 trials), United States (2 trials), Israel (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →